Is Biomea Fusion Inc (BMEA) overvalued? · $94.7M cap
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
This page asks whether Biomea Fusion Inc (BMEA) looks expensive on cached numbers — not a short thesis.
No cached income statement for BMEA, so there is no earnings base to call rich or cheap.
BMEA currently screens at market cap $94.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BMEA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BMEA stock page for the full model, not this heading.
Not investment advice.